(E)-3-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridine, 98%, 5g

6-Methyl-1,5,6,7-tetrahydro-4H-indol-4-one, 250mg

(3aS,7aR)-7a-phenylhexahydro-4H-pyrrolo[3,4-c]pyridine-4,6(5H)-dione, 95%, 250mg

Aminopropyl terminated Polydimethylsiloxane cSt 50-60, 100g

2-Ethynyl-4-fluoropyridine, 95%, 100mg

Cyclopropyl 2,4-dichlorophenyl ketone, 97.0%, 1g

6-Methylpiperidine-3-carboxylic acid, 95.0%, 1g

5-FLUORO-1-METHYL-1H-INDAZOL-3-AMINE, 95.0%, 250mg

2-(Cyclopropylmethoxy)isonicotinonitrile, 97%, 1g

1-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)ETHAN-1-OL, 95.0%, 1g

2-(4-Bromo-phenyl)-pyrrolidine hydrochloride, 96%, 250mg

2-Amino-5-(2-methoxyphenylcarbamoyl)-4-methyl-thiophene-3-carboxylic acid methyl ester, 1g

4-(4-Methyl-piperazin-1-yl)-4-oxo-butyric acid, 97.0%, 1g